Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells

Experimental Cell Research

Volumn 254, Issue 1, 2000, Pages 110-119

  Stone, Albert A ^a   Chambers, Timothy C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

ERK; JNK; MAP kinases; Microtubule inhibitors; p38

Indexed keywords

AGENTS AFFECTING CELL DIVISION; CASPASE 3; COLCHICINE; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VINBLASTINE; VINCRISTINE;

ARTICLE; CARCINOMA CELL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME KINETICS; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0034627879     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4731     Document Type: Article

References (30)

1. Cobb M. H., Goldsmith E. J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
2. Minden A., Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta. 1333:1997;F86-F104.
3. Kyriakis J. M., Avruch J. Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
4. Ip Y. T., Davis R. J. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development. Curr. Opin. Cell Biol. 10:1998;205-219.
5. Lewis T. S., Shapiro P. S., Ahn N. G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:1998;49-139.
6. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
7. Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincon M., Zheng T. S., Davis R. J., Rakic P., Flavell R. A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Science. 389:1997;865-870.
8. Liu Z-g., Hsu H., Goeddel D. V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:1996;565-576.
9. Johnson N. L., Gardner A. M., Diener K. M., Lange-Carter C. A., Gleavy J., Jarpe M. B., Minden A., Karin M., Zon L. I., Johnson G. L. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase induce cell death. J. Biol. Chem. 271:1996;3229-3237.
10. Nishina H., Fischer K. D., Radvanyi L., Shahinia A., Hakem R., Rubie E. A., Bernstein A., Mak T. W., Woodgett J. R., Penninger J. M. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature. 385:1997;350-353.
11. Potapova O., Haghighi A., Bost F., Liu C., Birrer M. J., Gjerset R., Mercola D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272:1997;14041-14044.
12. Krause A., Holtmann H., Eickemeier S., Winzen R., Szamel M., Resch K., Saklatvala J., Kracht M. Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J. Biol. Chem. 273:1998;23681-23689.
13. Kharbanda S., Ren R., Pandey P., Shafman T. D., Feller S. M., Weichselbaum R. R., Kufe D. W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature. 376:1995;785-788.
14. 2-terminal protein kinase pathway in the cellular response to doxorubicin and other chemotherapeutic drugs. J. Biol. Chem. 271:1996;30950-30955.
15. Wang T. H., Wang H. S., Ichijo H., Giannakakou P., Foster J. S., Fojo T., Wimalasena J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273:1998;4928-4936.
16. Shtil A. A., Mandlekar S., Yu R., Walter R. J., Hagen K., Tan T-H., Roninson I. B., Kong A-N. T. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene. 18:1999;377-384.
17. Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Derijard B., Davis R. J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
18. Blagosklonny M. V., Schulte T., Nguyen P., Trepel J., Neckers L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1996;1851-1854.
19. Blagosklonny M. V., Giannakakou P., El-Deiry W. S., Kingston D. G. I., Higgs P. I., Neckers L., Fojo T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 57:1997;130-135.
20. Torres K., Horwitz S. B. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res. 58:1998;3620-3626.
21. Widmann C., Gibson S., Johnson G. L. Caspase-dependent cleavage of signaling proteins during apoptosis: A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:1998;7141-7147.
22. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
23. Doroshow J. H. Anthracyclines and anthracenediones. Chabner B. A., Longo D. L. Cancer Chemotherapy and Biotherapy: Principles and Practice. 1996;406-434 Lippincott-Raven, Philadelphia.
24. Jarvis W. D., Fornari F. A., Auer K. L., Freemerman A. J., Szabo E., Birrer M. J., Johnson C. R., Barbour S. E., Dent P., Grant S. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol. 52:1997;935-947.
25. Yujiri T., Sather S., Fanger C. R., Johnson G. L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914.
26. Poruchynsky M. S., Wang E. E., Rudin C. M., Blagosklonny M. V., Fojo T. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Cancer Res. 58:1998;3331-3338.
27. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C., Gillieron C., Boschert U., Vial-Knecht E., Martinou J. C., Arkinstall S. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272:1997;25238-25242.
28. Wartmann M., Hofer P., Turowski P., Saltiel A. R., Hynes N. E. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J. Biol. Chem. 272:1997;3915-3923.
29. Kallunki T., Deng T., Hibi M., Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 87:1996;929-939.
30. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.